Dr. Mouhib Naddour says thymosin beta-4 shows promise only in lab and animal studies, and no unapproved peptide is cleared to treat lung disease.
Recap by typeshit. Full story at American Lung Association.
A new coroner's report connects the Australian actor's death to injecting peptides that were not approved. A serious marker for the safety debate around gray market peptides.
A new coroner's report ties the Australian actor's death to injecting peptides that weren't approved, a stark case for the safety debate.
A report ties the Australian actor's death to taking twice the intended amount of a peptide. Details on the coroner's findings are in the full story.
A Facebook share points to advice on how to adjust exercise while on a GLP-1, with no other details given.
The integrative medicine physician separates promising trial results and regulatory shifts from an actual approval of the drug.
A legal walkthrough of the 503A rules behind the October 28 policy, the July advisory vote, and the HHS note that it may revisit the policy if safety signals appear.
Loading…